APA-referens (7:e uppl.)

Liu, M., Ren, C., Zhang, H., Zhang, Y., Huang, Z., Jia, R., . . . Huo, L. (2024). Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging, 51(12), 3719-3730. https://doi.org/10.1007/s00259-024-06790-y

Chicago-referens (17:e uppl.)

Liu, Meixi, et al. "Evaluation of the Safety, Biodistribution, Dosimetry of [18F]AlF-NOTA-LM3 and Head-to-head Comparison with [68Ga]Ga-DOTATATE in Patients with Well-differentiated Neuroendocrine Tumors." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 12 (2024): 3719-3730. https://doi.org/10.1007/s00259-024-06790-y.

MLA-referens (9:e uppl.)

Liu, Meixi, et al. "Evaluation of the Safety, Biodistribution, Dosimetry of [18F]AlF-NOTA-LM3 and Head-to-head Comparison with [68Ga]Ga-DOTATATE in Patients with Well-differentiated Neuroendocrine Tumors." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 12, 2024, pp. 3719-3730, https://doi.org/10.1007/s00259-024-06790-y.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.